Description
Propylene Carbonate (CAS 108-32-7) is a high-performance polar-aprotic solvent vital to both pharmaceutical process chemistry (API synthesis, crystallization) and lithium-ion battery electrolytes. With rising EV adoption and expanding peptide-based drug pipelines, demand for battery- and pharma-grade Propylene Carbonate has surged over the past five years. This report delivers a detailed assessment of market size, pricing dynamics, supply–demand flows, and competitive benchmarking across purity grades (≥99% battery-grade; ≥99.5% pharma-grade).
What’s Driving Demand Now
EV battery boom: Global Li-ion battery capacity is set to exceed 1 TWh by 2028, driving battery-grade PC consumption by 18% CAGR.
Peptide API growth: Fast-growing biologics pipelines require high-purity PC for peptide coupling and crystallization, lifting pharma-grade volumes by 12% year-on-year.
Green-solvent push: Regulatory trends favor CO₂-based solvent routes, enhancing Propylene Carbonate’s appeal as a low-toxicity alternative.
Producers with Export-Ready Capacity
Dow Inc. (USA): World’s largest capacity, integrated PO–PC complex
UBE Industries (Japan): Dedicated battery-grade lines with moisture < 10 ppm
Mitsubishi Chemical (Japan): Pharma-grade PC with USP/EP certification
Shandong Haohua (China): Rapidly expanded PC plant to serve EU battery OEMs
Shenzhen Huaxu Chemical (China): Custom‐synthesis for peptide drug CDMOs
Market Size & Forecast (2020–2030)
• By Volume (t) & Value (USD M)
• Breakdown by Grade: Battery-, Pharma-, Technical-
• CAGR and Key Growth Drivers
End-Use Demand Analysis
• Battery-Grade: Li-ion electrolytes, capacitors
• Pharma-Grade: Peptide coupling, API crystallization
• Technical-Grade: Coatings, specialty solvents
Verified Manufacturers & Supply Landscape
• Company profiles and plant locations
• Purity-grade capabilities and capacity shares
• Certification status (ISO, USP/EP, battery-grade specs)
Pricing Trends & Margin Analysis
• Historical spot vs. contract prices (2018–2024)
• Feedstock (propylene oxide, CO₂) cost pass-through
• Grade‐based price differentials and margins
Export-Import Trade Flow (2020–2024)
• Major trade lanes (Asia → North America, Europe → Asia)
• HS code analysis and tariff impacts
• Logistics & lead-time considerations
Strategic Drivers & Recent Developments
• New battery-grade plant announcements
• Pharma CDMO partnerships for high-purity PC
• Sustainability initiatives and green-PC production
Supply Chain Risk & Opportunity Mapping
• Geographic concentration and feedstock bottlenecks
• Alternative sourcing scenarios (CO₂ capture, biogenic routes)
• Short- and mid-term investment hotspots
Strategic Recommendations
• For battery manufacturers and cathode formulators
• For pharma CDMOs and API sourcing teams
• For specialty chemical investors
Appendices
• CAS number, synonyms, molecular properties
• Research methodology & data sources
• Regulatory and patent landscape
Reviews
There are no reviews yet.